Form 8-K - Current report:
SEC Accession No. 0001746473-23-000007
Filing Date
2023-03-09
Accepted
2023-03-09 16:11:35
Documents
14
Period of Report
2023-03-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K plrx-20230309.htm   iXBRL 8-K 39845
2 EX-99.1 a4q2022exhibit991.htm EX-99.1 90920
6 GRAPHIC image_0.jpg GRAPHIC 13148
  Complete submission text file 0001746473-23-000007.txt   296005

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT plrx-20230309.xsd EX-101.SCH 1902
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT plrx-20230309_lab.xml EX-101.LAB 23832
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT plrx-20230309_pre.xml EX-101.PRE 12508
8 EXTRACTED XBRL INSTANCE DOCUMENT plrx-20230309_htm.xml XML 11297
Mailing Address 260 LITTLEFIELD AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 260 LITTLEFIELD AVENUE SOUTH SAN FRANCISCO CA 94080 650-481-6770
PLIANT THERAPEUTICS, INC. (Filer) CIK: 0001746473 (see all company filings)

EIN.: 474272481 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39303 | Film No.: 23719862
SIC: 2834 Pharmaceutical Preparations